Possible relationship between certolizumab pegol and arrhythmias: report of two cases

Possible relationship between certolizumab pegol and arrhythmias: report of two cases

It is still unknown whether there is an association between the use of certolizumab pegol (CZP) in rheumatic patients and the onset of cardiac arrhythmias. We describe the cases of two patients with rheumatoid arthritis (RA) treated with CZP as the first-line biological drug and methotrexate (MTX),...

Full description

Bibliographic Details
Main Authors: R. Talotta, F. Atzeni, A. Batticciotto, D. Ventura, P. Sarzi-Puttini
Format: Article
Language:English
Published: PAGEPress Publications 2016-09-01
Series:Reumatismo
Subjects:
Anti-TNF drugs
heart diseases
rheumatoid arthritis
arrhythmia.
Online Access:http://www.reumatismo.org/index.php/reuma/article/view/869

Internet

http://www.reumatismo.org/index.php/reuma/article/view/869

Similar Items